Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Aeterna Zentaris Inc T.AEZS

Alternate Symbol(s):  AEZS

Aeterna Zentaris Inc. is a Canada-based specialty biopharmaceutical company. The Company is developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products focused on areas of significant unmet medical need. The Company's lead product, macimorelin (Macrilen, Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (TSX:AEZS)

Aeterna Zentaris Announces Effective Date of Share Consolidation

GlobeNewswire 6 days ago

Ceapro Receives Final Court Approval for Merger with Aeterna Zentaris

GlobeNewswire March 28, 2024

Aeterna Zentaris Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Completion of Enrollment in Ongoing Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency

GlobeNewswire March 27, 2024

Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings

GlobeNewswire March 12, 2024

Leading Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders Vote FOR the Arrangement Agreement to Approve the Merger of Equals to Create a Diversified Biopharmaceutical Company

GlobeNewswire February 26, 2024

Aeterna Zentaris Issues Letter to Shareholders and Management Proxy Circular Ahead of Special Meeting of Shareholders to Approve Merger of Equals with Ceapro

GlobeNewswire February 15, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVLY, EVFM, AEZS, HOLI

PR Newswire December 19, 2023

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Aeterna Zentaris Inc. Merger

Newsfile December 18, 2023

Lifshitz Law PLLC Announces Investigations of ORRF, RAIN, BLBX, and AEZS

Accesswire December 15, 2023

Opinion & Analysis (TSX:AEZS)

No current opinion is available.

Bullboard Posts (TSX:AEZS)

AEZS announced stock split 1-4

BREAKING NEWS: $AEZS AEZS announced stock split 1-42024-05-03 09:02:04 ET Aeterna Zentaris Inc. (AEZS) announced stock split at a ratio...
whytestocks - 4 days ago

RE:RE:Why investors should be wary of 'mergers of equals'

[img]
Ciao - March 29, 2024

RE:Why investors should be wary of 'mergers of equals'

[img] AEZS shareholder value destruction [/img]
Ciao - March 29, 2024

Why investors should be wary of 'mergers of equals'

https://financialpost.com/financial-times/investors-wary-of-mergers-of-equals#:~:text=And%20the%20record%20of%20the,over%20the...
lscfa - March 10, 2024

Don’t wait for mail out to arrive

Call your broker....Ask for a control no. for voting purposes....Go to www.proxyvote.com and vote NO.
lscfa - February 18, 2024

RE:RE:For you AEZS shareholder

Gilles has no credibility by missing all targets he has set in the past on licensing deals (CoQ10 in H2 2023, functional drink by 2020...
Ciao - January 23, 2024